Fasting Blood Glucose

Q: Why measure fasting glucose if my HbA1c is already normal?

HbA1c reflects a three-month glucose average but does not capture regulation at rest. Fasting glucose reveals the liver and pancreas's ability to maintain glucose balance without food intake. A normal HbA1c can coexist with gradually rising fasting glucose, signaling a metabolic shift that the average alone does not reveal.

Q: My fasting glucose is slightly above the optimal range. What does this result mean?

A slightly elevated value may reflect several situations. Early insulin resistance, recurrent stress, insufficient sleep, or too short a fasting period are common examples. The draw context and trends across several panels are more informative than a single reading. Pairing with fasting insulin and HOMA-IR helps clarify the source of the elevation.

Q: How often should I measure my fasting blood glucose?

Frequency depends on individual profile. For preventive monitoring, testing every six to twelve months allows trajectory observation. If values fall in the elevated range or if other metabolic markers are altered, closer monitoring may be relevant. The trend over time is always more informative than a single measurement.

Q: What is the relationship between fasting glucose and HOMA-IR?

HOMA-IR is an index calculated from fasting glucose and fasting insulin. It quantifies insulin resistance: the body's ability to manage glucose with a given amount of insulin. Glucose alone does not reveal the pancreatic effort needed to maintain it. Two people with the same glucose level can have very different insulin levels, and therefore distinct metabolic profiles.

Q: Can physical activity influence my fasting glucose result?

Regular exercise improves insulin sensitivity and tends to bring fasting glucose back to the optimal range over the long term. However, very intense effort the day before the blood draw can temporarily lower glucose. For a representative result, it is best to avoid unusual exertion in the 24 hours before the blood draw.

Fasting Glucose · Fasting blood glucose · FBG · FPG

Glycemia & Metabolism

Fasting blood glucose is one of the oldest and most predictive markers of metabolic aging. Its trajectory over time, more than any single reading, reveals the body's ability to maintain glucose homeostasis at rest. Large-scale cohort studies confirm this link. Fasting glucose maintained in the optimal range is associated with reduced long-term cardiovascular and metabolic risk.

Last updated: August 17, 2026

Physiological Role

Glucose is the body's primary energy source. Every cell uses it to produce ATP (adenosine triphosphate), the universal energy molecule. The brain, representing roughly 2% of body mass, alone consumes 20% of circulating glucose.

Blood sugar regulation relies on a precise hormonal balance. After a meal, the pancreas secretes insulin to facilitate glucose entry into cells. During fasting, it releases glucagon to mobilize liver glycogen stores and maintain a steady supply to the brain and vital organs.

Fasting blood glucose, measured after 8 to 12 hours without food intake, reflects this baseline regulation. It captures the liver's ability to produce the right amount of glucose and tissue sensitivity to residual insulin. An imbalance between these two mechanisms gradually shifts fasting glucose levels.

Reference Ranges

Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.

Very Low≤ 55 mg/dL

Low> 55 – < 80 mg/dL

Optimal≥ 80 – ≤ 90 mg/dL

High> 90 – ≤ 99.9 mg/dL

Very High> 99.9 mg/dL

Biological Significance

Fasting glucose in the optimal range indicates that the pancreas and liver are working efficiently together to maintain glucose homeostasis at rest. Glucose is produced in appropriate amounts and tissues respond normally.

Elevated values, even moderately above the optimal range, signal a shift in this balance. They may reflect emerging insulin resistance, hepatic glucose overproduction, or both simultaneously. This evolution is often gradual and can be observed across several successive blood panels.

Low values also warrant attention. They may result from fasting beyond the recommended 12 hours or from intense physical exercise the day before the blood draw. Below the optimal range, large population cohorts observe no further benefit, and all-cause mortality rises again. A low value then usually reflects another state of the body, without glucose being its cause. The context of the blood draw remains essential for interpreting a low result.

Fasting blood glucose reaches its full dimension when paired with fasting insulin and HOMA-IR. Together, these three markers paint a complete picture of glucose metabolic function.

Influencing Factors

Diet. Meal composition directly influences baseline blood sugar. Chronically high intake of refined carbohydrates and added sugars challenges the pancreas and can gradually impair insulin sensitivity. Dietary fiber, protein and fats slow glucose absorption and contribute to glycemic stability.

Physical activity. Regular exercise improves insulin sensitivity and glucose uptake by skeletal muscles. This effect persists 24 to 48 hours after exertion. A sedentary lifestyle is associated with gradual increases in fasting glucose over the years.

Sleep. Sleep debt, even over just a few nights, impairs glucose tolerance and increases insulin resistance. Studies show that sleeping less than six hours per night is associated with higher fasting blood glucose.

Stress. Cortisol, a hormone released in response to chronic stress, stimulates hepatic glucose production. Prolonged stress exposure can keep fasting glucose above the physiological baseline.

Body composition. Visceral adiposity, fat accumulated around the abdominal organs, is a major driver of insulin resistance. Visceral fat loss is one of the most well-documented levers for bringing fasting blood glucose back to the optimal range.

Age. Insulin sensitivity naturally decreases with age. This decline contributes to the gradual rise in fasting glucose observed in population studies, independently of lifestyle factors.

Sample handling. Red blood cells keep consuming glucose inside the tube after the blood draw. The result therefore drops by a few milligrams per hour of waiting before centrifugation, depending on the tube used and the transport delay. This explains part of the gap observed between two draws, without glucose regulation having changed.

In the Singular Formula

Fasting blood glucose is an adjustment parameter in the Singular formulation engine. When it sits in the high or very high range, taurine dosage is raised to its reinforced level and dietary guidance content is delivered. Fasting insulin, HbA1c and HOMA-IR trigger the same rule, each independently.

It also participates in calculating HOMA-IR. This insulin resistance index is derived from fasting glucose and fasting insulin. HOMA-IR provides a more nuanced view of metabolic function than glucose alone, by revealing the pancreatic effort required to maintain glycemic balance. When HOMA-IR is elevated, a separate safety rule removes glucosamine sulfate from the formula.

Magnesium is part of the base formula. Its dosage is not adjusted based on fasting glucose levels.

Fasting blood glucose is measured alongside fasting insulin and HbA1c, providing a complete map of glucose metabolism. This combined approach helps distinguish elevated glucose due to insulin resistance from elevated glucose due to hepatic overproduction.

Linked Bioactives

Taurine Ginger Sulforaphane Glucosamine

Scientific Studies

Authors	Year	Type	Journal
Emerging Risk Factors Collaboration	2010	Meta-analysis	Lancet	View on PubMed
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Meta-analysis of 102 prospective studies and 698,782 participants. The link between fasting glucose and vascular risk is not linear: no significant association appears between 3.90 and 5.59 mmol/L, roughly 70 to 100 mg/dL, and risk rises above that.
Coutinho M et al.	1999	Meta-analysis	Diabetes Care	View on PubMed
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Metaregression of 20 studies, 95,783 individuals followed for 12.4 years on average, 94% of them men. Against a reference point of 4.2 mmol/L, about 75 mg/dL, cardiovascular risk rises continuously, including below the conventional diabetes threshold.
Bjørnholt JV et al.	1999	Cohort Study	Diabetes Care	View on PubMed
Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men 22-year prospective cohort of 1,973 non-diabetic men aged 40 to 59. The upper quartile, above 85 mg/dL, carries higher cardiovascular mortality. The published abstract does not state whether the measurement is whole blood or plasma.
Cai X et al.	2020	Meta-analysis	BMJ	View on PubMed
Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis Updated meta-analysis of 129 studies and over 10 million participants. Prediabetes is associated with increased all-cause mortality and cardiovascular events. Impaired glucose tolerance carries a higher risk than raised fasting glucose alone.
Matthews DR et al.	1985	Clinical Trial	Diabetologia	View on PubMed
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Foundational article on the HOMA model. Describes the calculation of insulin resistance and beta-cell function from fasting glucose and insulin levels. Methodological reference for metabolic assessment.
Yi SW et al.	2017	Cohort Study	Scientific Reports	View on PubMed
Association between fasting glucose and all-cause mortality according to sex and age: a prospective cohort study Cohort of 12,455,361 Korean adults examined between 2001 and 2004 and followed through 2013. The lowest all-cause mortality is observed between 80 and 94 mg/dL, regardless of sex and age. It is the largest published analysis of this relationship.
Wei M et al.	2000	Cohort Study	Circulation	View on PubMed
Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality Cohort of 40,069 men and women. Against a reference band of 80 to 109 mg/dL, cardiovascular mortality is 3.3 times higher below 70 mg/dL and 2.4 times higher between 70 and 79 mg/dL.

Frequently Asked Questions

Why measure fasting glucose if my HbA1c is already normal?#[ + ]

My fasting glucose is slightly above the optimal range. What does this result mean?#[ + ]

How do the Singular ranges relate to the usual clinical reference points?#[ + ]

They answer two different questions. The Singular ranges describe the band associated with the lowest mortality in large population cohorts. The usual clinical reference points sit higher: 100 mg/dL marks the start of impaired fasting glucose, often called prediabetes, and 126 mg/dL the start of diabetes. A value above the Singular optimal range can therefore still sit below the first of those two reference points.

How often should I measure my fasting blood glucose?#[ + ]

What is the relationship between fasting glucose and HOMA-IR?#[ + ]

Can physical activity influence my fasting glucose result?#[ + ]

The information on this page is provided for informational and educational purposes only. It does not constitute medical advice and is not a substitute for consultation with a healthcare professional.

Discover all biomarkers